SEC Company Response from VivoSim Labs, INC. (VIVS) (CIK 0001497253) (VIVS) — Feb 20, 2018
VivoSim Labs, INC. (VIVS) (CIK 0001497253)
Date: Feb. 20, 2018 · CIK: 0001497253 · Accession: 0001193125-18-050616
AI Filing Summary & Sentiment
File numbers found in text: 333-222929
Show Raw Text
CORRESP 1 filename1.htm CORRESP February 20, 2018 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4546 Washington, D.C. 20549 Attention: Ms. Ada D. Sarmento, Senior Counsel Re: Acceleration Request of Organovo Holdings, Inc. Registration Statement on Form S-3, filed February 8, 2018 (File No. 333-222929) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Organovo Holdings, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Thursday, February 22, 2018, or as soon thereafter as practicable. Thank you for your assistance. If you should have any questions, please contact Ryan Gunderson of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8046. Very truly yours, /s/ Craig Kussman Craig Kussman Chief Financial Officer